TY  - JOUR
AU  - Fernandez-Peralbo, M. A.
AU  - Gomez-Gomez, E.
AU  - Calderon-Santiago, M.
AU  - Carrasco-Valiente, J.
AU  - Ruiz-Garcia, J.
AU  - Requena-Tapia, M. J.
AU  - Luque de Castro, M. D.
AU  - Priego-Capote, F.
PY  - 2016
DO  - 10.1038/srep38243
SN  - 2045-2322
UR  - http://hdl.handle.net/10668/18914
T2  - Scientific reports
AB  - The existing clinical biomarkers for prostate cancer (PCa) diagnosis are far from ideal (e.g., the prostate specific antigen (PSA) serum level suffers from lack of specificity, providing frequent false positives leading to over-diagnosis). A key step...
LA  - en
PB  - Nature Publishing Group
KW  - Dna demethylation
KW  - Methylation
KW  - 5-hydroxymethylcytosine
KW  - 5-methylcytosine
KW  - Identification
KW  - Progression
KW  - Biomarkers
KW  - Conversion
KW  - Sarcosine
KW  - Histones
KW  - Prostate-specific antigen
KW  - Discriminant analysis
KW  - Least-squares analysis
KW  - Overdiagnosis
KW  - Prostatic neoplasms
TI  - Prostate Cancer Patients-Negative Biopsy Controls Discrimination by Untargeted Metabolomics Analysis of Urine by LC-QTOF: Upstream Information on Other Omics
TY  - research article
VL  - 6
ER  -